Adolore Biotherapeutics, Inc. reported raising $250,000 in an initial SEC Form D filing, from an offering of $2.5 Million
Amount Raised
$250,000
Round Type
Venture
Delray BeachBiotechnologyresearchWho else raised in research and Biotechnology around the same time
Companies in the same sectors as Adolore Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- Kernal Biologics raised $20M on February 25, 2022.
- Dewpoint Therapeutics raised $150M on February 4, 2022.
- Dewpoint Therapeutics raised $150M (Series C) on February 3, 2022.
- Leyden Labs raised $200M (Funding Round) on January 25, 2022.
- Faeth Therapeutics raised $20M (Seed) on January 18, 2022.
- Gameto raised $27M on January 11, 2022.
Who to call at Adolore Biotherapeutics, and when
A new round usually means Adolore Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Adolore Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adolore Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adolore Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adolore Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Adolore Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.